GB0516661D0 - Therapeutic agents - Google Patents
Therapeutic agentsInfo
- Publication number
- GB0516661D0 GB0516661D0 GBGB0516661.6A GB0516661A GB0516661D0 GB 0516661 D0 GB0516661 D0 GB 0516661D0 GB 0516661 A GB0516661 A GB 0516661A GB 0516661 D0 GB0516661 D0 GB 0516661D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic agents
- therapeutic
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Communicable Diseases (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0516661.6A GB0516661D0 (en) | 2005-08-13 | 2005-08-13 | Therapeutic agents |
TW095128062A TW200728300A (en) | 2005-08-13 | 2006-08-01 | Therapeutic agents |
ARP060103449A AR055368A1 (en) | 2005-08-13 | 2006-08-08 | DERIVATIVES OF PIRAZOL, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN THE PREPARATION OF MEDICINES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES AND OBESITY |
KR1020087004570A KR20080039939A (en) | 2005-08-13 | 2006-08-09 | Pyrazole derivatives as therapeutic agents |
EP06779114A EP1915364A1 (en) | 2005-08-13 | 2006-08-09 | Pyrazole derivatives as therapeutic agents |
MX2008002065A MX2008002065A (en) | 2005-08-13 | 2006-08-09 | Pyrazole derivatives as therapeutic agents. |
CNA2006800374501A CN101282963A (en) | 2005-08-13 | 2006-08-09 | Pyrazole derivatives as therapeutic agents |
PCT/GB2006/002990 WO2007020388A1 (en) | 2005-08-13 | 2006-08-09 | Pyrazole derivatives as therapeutic agents |
RU2008108179/04A RU2008108179A (en) | 2005-08-13 | 2006-08-09 | PYRAZOLE DERIVATIVES AS THERAPEUTIC AGENTS |
CA002619228A CA2619228A1 (en) | 2005-08-13 | 2006-08-09 | Pyrazole derivatives as therapeutic agents |
AU2006281300A AU2006281300A1 (en) | 2005-08-13 | 2006-08-09 | Pyrazole derivatives as therapeutic agents |
JP2008526536A JP2009504717A (en) | 2005-08-13 | 2006-08-09 | Pyrazole derivatives as therapeutic agents |
BRPI0614626-0A BRPI0614626A2 (en) | 2005-08-13 | 2006-08-09 | compound, pharmaceutical formulation, use of a compound, and method for treating disease |
UY29741A UY29741A1 (en) | 2005-08-13 | 2006-08-11 | SALTS OF 1,5- DIARIL PIRAZOL-3-CARBOXAMIDS, PREPARATION PROCESSES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, APPLICATIONS AND METHODS OF USE. |
IL188759A IL188759A0 (en) | 2005-08-13 | 2008-01-14 | Pyrazole derivatives as therapeutic agents |
NO20080372A NO20080372L (en) | 2005-08-13 | 2008-01-21 | Pyrazole derivatives as therapeutic agents |
ZA200800698A ZA200800698B (en) | 2005-08-13 | 2008-01-23 | Pyrazole derivatives as therapeutic agents |
EC2008008250A ECSP088250A (en) | 2005-08-13 | 2008-03-07 | DERIVATIVES OF PIRAZOL AS THERAPEUTIC AGENTS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0516661.6A GB0516661D0 (en) | 2005-08-13 | 2005-08-13 | Therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0516661D0 true GB0516661D0 (en) | 2005-09-21 |
Family
ID=35098275
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0516661.6A Ceased GB0516661D0 (en) | 2005-08-13 | 2005-08-13 | Therapeutic agents |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1915364A1 (en) |
JP (1) | JP2009504717A (en) |
KR (1) | KR20080039939A (en) |
CN (1) | CN101282963A (en) |
AR (1) | AR055368A1 (en) |
AU (1) | AU2006281300A1 (en) |
BR (1) | BRPI0614626A2 (en) |
CA (1) | CA2619228A1 (en) |
EC (1) | ECSP088250A (en) |
GB (1) | GB0516661D0 (en) |
IL (1) | IL188759A0 (en) |
MX (1) | MX2008002065A (en) |
NO (1) | NO20080372L (en) |
RU (1) | RU2008108179A (en) |
TW (1) | TW200728300A (en) |
UY (1) | UY29741A1 (en) |
WO (1) | WO2007020388A1 (en) |
ZA (1) | ZA200800698B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102008015033A1 (en) | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituted (pyrazolyl-carbonyl) imidazolidinones and their use |
DE102008015032A1 (en) | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituted pyrazolamides and their use |
DE102008062878A1 (en) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituted furancarboxamides and their use |
DE102008062863A1 (en) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituted (thiophenyl-carbonyl) imidazolidinones and their use |
DE102009036604A1 (en) | 2009-07-30 | 2011-02-03 | Aicuris Gmbh & Co. Kg | Substituted bis-arylpyrazolamides with terminal primary amide functionality and their use |
DE102011055815A1 (en) | 2011-11-29 | 2013-05-29 | Aicuris Gmbh & Co. Kg | Carboxamide-substituted heteroaryl-pyrazoles and their use |
DE102012016908A1 (en) | 2012-08-17 | 2014-02-20 | Aicuris Gmbh & Co. Kg | Tris (hetero) aryl-pyrazoles and their use |
CN105061227A (en) * | 2015-07-27 | 2015-11-18 | 广东先强药业有限公司 | Environment-friendly ritodrine hydrochloride production method |
US11548875B2 (en) | 2018-12-12 | 2023-01-10 | University Of Washington | Inhibitor compounds for male contraception |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4419078B2 (en) * | 2002-12-02 | 2010-02-24 | アステラス製薬株式会社 | Pyrazole derivative |
US7247628B2 (en) * | 2002-12-12 | 2007-07-24 | Pfizer, Inc. | Cannabinoid receptor ligands and uses thereof |
ATE440085T1 (en) * | 2004-02-20 | 2009-09-15 | Astrazeneca Ab | 3-SUBSTITUTED 1,5-DIPHENYLPYRAZOLE DERIVATIVES SUITABLE AS CB1 MODULATORS |
-
2005
- 2005-08-13 GB GBGB0516661.6A patent/GB0516661D0/en not_active Ceased
-
2006
- 2006-08-01 TW TW095128062A patent/TW200728300A/en unknown
- 2006-08-08 AR ARP060103449A patent/AR055368A1/en unknown
- 2006-08-09 KR KR1020087004570A patent/KR20080039939A/en not_active Application Discontinuation
- 2006-08-09 CN CNA2006800374501A patent/CN101282963A/en active Pending
- 2006-08-09 RU RU2008108179/04A patent/RU2008108179A/en not_active Application Discontinuation
- 2006-08-09 JP JP2008526536A patent/JP2009504717A/en active Pending
- 2006-08-09 EP EP06779114A patent/EP1915364A1/en not_active Withdrawn
- 2006-08-09 CA CA002619228A patent/CA2619228A1/en not_active Abandoned
- 2006-08-09 BR BRPI0614626-0A patent/BRPI0614626A2/en not_active Application Discontinuation
- 2006-08-09 AU AU2006281300A patent/AU2006281300A1/en not_active Abandoned
- 2006-08-09 WO PCT/GB2006/002990 patent/WO2007020388A1/en active Application Filing
- 2006-08-09 MX MX2008002065A patent/MX2008002065A/en not_active Application Discontinuation
- 2006-08-11 UY UY29741A patent/UY29741A1/en not_active Application Discontinuation
-
2008
- 2008-01-14 IL IL188759A patent/IL188759A0/en unknown
- 2008-01-21 NO NO20080372A patent/NO20080372L/en not_active Application Discontinuation
- 2008-01-23 ZA ZA200800698A patent/ZA200800698B/en unknown
- 2008-03-07 EC EC2008008250A patent/ECSP088250A/en unknown
Also Published As
Publication number | Publication date |
---|---|
UY29741A1 (en) | 2007-03-30 |
WO2007020388A1 (en) | 2007-02-22 |
NO20080372L (en) | 2008-04-16 |
AR055368A1 (en) | 2007-08-22 |
ECSP088250A (en) | 2008-04-28 |
CA2619228A1 (en) | 2007-02-22 |
IL188759A0 (en) | 2008-08-07 |
EP1915364A1 (en) | 2008-04-30 |
JP2009504717A (en) | 2009-02-05 |
KR20080039939A (en) | 2008-05-07 |
TW200728300A (en) | 2007-08-01 |
MX2008002065A (en) | 2008-04-16 |
BRPI0614626A2 (en) | 2012-12-04 |
ZA200800698B (en) | 2009-01-28 |
AU2006281300A1 (en) | 2007-02-22 |
RU2008108179A (en) | 2009-09-20 |
CN101282963A (en) | 2008-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1962961A4 (en) | Demibodies: dimerisation-activated therapeutic agents | |
EP1730148A4 (en) | Aminobenzoxazoles as therapeutic agents | |
GB0506147D0 (en) | Therapeutic agents | |
GB0615545D0 (en) | Therapeutic agent | |
GB0521139D0 (en) | Therapeutic agent | |
GB0403780D0 (en) | Therapeutic agents | |
GB0519797D0 (en) | Therapeutic agents | |
GB0505725D0 (en) | Therapeutic agents | |
GB0505437D0 (en) | Therapeutic agents | |
GB0519350D0 (en) | Therapeutic agents | |
GB0518819D0 (en) | Therapeutic agents | |
GB0518817D0 (en) | Therapeutic agents | |
GB0516661D0 (en) | Therapeutic agents | |
GB0514738D0 (en) | Therapeutic agents | |
GB0507003D0 (en) | Therapeutic | |
GB0518720D0 (en) | Therapeutic combination | |
GB0501655D0 (en) | Therapeutic use | |
GB0523998D0 (en) | Therapeutic agents | |
GB0400193D0 (en) | Therapeutic agents | |
GB0508153D0 (en) | Therapeutic agent | |
GB0522433D0 (en) | Therapeutic agents | |
GB0403779D0 (en) | Therapeutic agents | |
GB0402918D0 (en) | Therapeutic agents | |
GB0400196D0 (en) | Therapeutic agents | |
GB0511903D0 (en) | Therapeutic agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |